Lidocaine Hydrochloride Patent Expiration

Lidocaine Hydrochloride is Used for providing local anesthesia with the delivery of powdered lidocaine hydrochloride monohydrate. It was first introduced by Fresenius Kabi Usa Llc in its drug Xylocaine on Approved Prior to Jan 1, 1982. Other drugs containing Lidocaine Hydrochloride are Xylocaine Dental, Akten, Lidocaine Hydrochloride 0.2% And Dextrose 5% In Plastic Container, Xylocaine 1.5% W/ Dextrose 7.5%, Lidocaine Hydrochloride 0.8% In Dextrose 5% In Plastic Container, Xylocaine 4% Preservative Free, Lidocaine Hydrochloride Preservative Free, Xylocaine Viscous, Xylocaine Preservative Free, Lidocaine Hydrochloride 0.4% In Dextrose 5% In Plastic Container, Lidocaine Hydrochloride 0.1% And Dextrose 5% In Plastic Container, Lidocaine Hydrochloride 0.2% In Dextrose 5% In Plastic Container, Lidocaine Hydrochloride 0.4% And Dextrose 5% In Plastic Container, Lidopen, Lidocaine Hydrochloride 0.8% And Dextrose 5% In Plastic Container, Xylocaine 5% W/ Glucose 7.5%, Lidocaine Hydrochloride, Zingo. 55 different companies have introduced drugs containing Lidocaine Hydrochloride.


Lidocaine Hydrochloride Patents

Given below is the list of patents protecting Lidocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zingo US9370622 Devices and methods for delivering particles Sep 28, 2035 Powder Pharms
Zingo US9358338 Particle cassettes and processes therefor Apr 27, 2035 Powder Pharms
Zingo US8540665 Particle cassettes and processes therefor Oct 22, 2029 Powder Pharms
Akten US8759401 Aqueous gel formulation and method for inducing topical anesthesia Jul 24, 2026 Thea Pharma
Zingo US6004286 Particle delivery Mar 17, 2017

(Expired)

Powder Pharms
Zingo US6881200 Needleless syringe using super sonic gas flow for particle delivery Jun 11, 2016

(Expired)

Powder Pharms
Zingo US5899880 Needleless syringe using supersonic gas flow for particle delivery May 04, 2016

(Expired)

Powder Pharms
Zingo US5630796 Method of delivering powder transdermally with needless injector May 20, 2014

(Expired)

Powder Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lidocaine Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Lidocaine Hydrochloride.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 12 Feb, 2024 US9370622
Payment of Maintenance Fee, 8th Yr, Small Entity 05 Mar, 2021 US8540665
Payment of Maintenance Fee, 4th Yr, Small Entity 03 Jul, 2019 US9370622
Recordation of Patent Grant Mailed 21 Jun, 2016 US9370622
Patent Issue Date Used in PTA Calculation 21 Jun, 2016 US9370622
Issue Notification Mailed 01 Jun, 2016 US9370622
Dispatch to FDC 24 May, 2016 US9370622
Application Is Considered Ready for Issue 20 May, 2016 US9370622
Issue Fee Payment Verified 20 May, 2016 US9370622
Issue Fee Payment Received 20 May, 2016 US9370622


Lidocaine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lidocaine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Lidocaine Hydrochloride. The first generic version for Lidocaine Hydrochloride was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Anthea Pharma Private Ltd and was approved on Apr 2, 2025.

Given below is the list of companies who have filed for Lidocaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.